Protalix Biotherapeutics Inc (PLX)
Healthcare
Biotechnology
2.40 $
+4.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Protalix Biotherapeutics Inc (PLX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.1% of the shares are freely tradable; institutional investors hold 21.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
21.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
3.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
96.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
81Mio.
No ownership data is available for this stock yet.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.